Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureLeslie L. Davis, Eugene Yang, Ciantel Adair Blyler, Jennifer L. Cluett, Stephen P. Juraschek, John P. Reilly, Kardie Tobb
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
No local reference links have been materialized yet.
No local citing links have been materialized yet.
2026 heart disease and stroke statistics: a report of US and global data from the American Heart Association
10.1161/cir.0000000000001412 · 2026
10.1016/j.jacc.2025.05.007
10.1016/j.jacc.2025.05.007 · 2025
Prevalence of apparent treatment-resistant hypertension in the United States
10.1161/hypertensionaha.118.12191 · 2019
Characterization of individuals with apparent resistant hypertension using contemporary guidelines: insights from CV-QUIC
10.1161/hypertensionaha.123.20894 · 2023
Prevalence of apparent treatment-resistant hypertension in the United States according to the 2017 high blood pressure guideline
10.1016/j.mayocp.2018.12.033 · 2019
Hypertensive disorders of pregnancy
2024
Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review
10.1097/hjh.0000000000001197 · 2017
Optimizing observer performance of clinic blood pressure measurement: a position statement from the Lancet Commission on Hypertension Group
10.1097/hjh.0000000000002112 · 2019
Sphygmomanometer calibration—why, how and how often?
2007
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure
10.1097/hjh.0000000000002246 · 2020
STRIDE BP: an international initiative for accurate blood pressure measurement
10.1097/hjh.0000000000002289 · 2020
STRIDE BP international initiative for accurate blood pressure measurement: systematic review of published validation studies of blood pressure measuring devices
10.1111/jch.13710 · 2019
Blood pressure measurement in atrial fibrillation: review and meta-analysis of evidence on accuracy and clinical relevance
10.1097/hjh.0000000000002201 · 2019
Effects of cuff size on the accuracy of blood pressure readings: the Cuff(SZ) randomized crossover trial
10.1001/jamainternmed.2023.3264 · 2023
Measurement of blood pressure in humans: a scientific statement from the American Heart Association
10.1161/hyp.0000000000000087 · 2019
Only troncoconical cuffs can provide accurate blood pressure measurements in people with severe obesity
10.1097/hjh.0000000000001823 · 2019
2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension
10.1097/hjh.0000000000003480 · 2023
2024 ESC guidelines for the management of elevated blood pressure and hypertension
10.1093/eurheartj/ehae178 · 2024
Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
2020
Agreement between different types of blood pressure monitoring: a systematic review and network meta-analysis
10.7326/annals-24-02142 · 2025
Effects of different rest period durations prior to blood pressure measurement: the best REST trial
10.1161/hypertensionaha.121.17496 · 2021
Impact of 30- versus 60-second time intervals between automated office blood pressure measurements on measured blood pressure
10.1161/hypertensionaha.121.17876 · 2021
Clinical impact of 3- vs. 5-minute delay and 30- vs. 60-second intervals on unattended automated office blood pressure measurements
10.1093/ajh/hpae135 · 2025
Orthostatic hypotension in adults with hypertension: a scientific statement from the American Heart Association
10.1161/hyp.0000000000000236 · 2024
Orthostatic hypotension in hypertensive adults: Harry Goldblatt award for early career investigators 2021
10.1161/hypertensionaha.122.18557 · 2022
Screening for hypertension in adults: US preventive services task force reaffirmation recommendation statement
10.1001/jama.2021.4987 · 2021
Screening for hypertension in adults: updated evidence report and systematic review for the US preventive services task force
10.1001/jama.2020.21669 · 2021
Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association
10.1161/cir.0000000000000803 · 2020
Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force
10.7326/m14-1539 · 2015
Prognostic value of masked uncontrolled hypertension
10.1161/hypertensionaha.118.11499 · 2018
Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis
10.7326/m19-0223 · 2019
Reliability of office, home, and ambulatory blood pressure measurements and correlation with left ventricular mass
10.1016/j.jacc.2020.10.039 · 2020
Comparison of home and office blood pressure devices in the clinical setting
10.1093/ajh/hpad120 · 2024
Nocturnal hypertension: new technology and evidence
10.1161/hypertensionaha.118.10971 · 2018
Association between non-dipper blood pressure pattern and coronary artery disease burden in hypertensive patients
10.1080/14779072.2025.2569399 · 2025
Number of measurements needed to obtain a reliable estimate of home blood pressure: results from the improving the detection of hypertension study
10.1161/jaha.118.008658 · 2018
The optimal home blood pressure monitoring schedule based on the Didima outcome study
10.1038/jhh.2009.54 · 2010
Schedules for self-monitoring blood pressure: a systematic review
10.1093/ajh/hpy185 · 2019
10.1016/j.jacc.2017.11.006
10.1016/j.jacc.2017.11.006 · 2018
Design and implementation of an electronic health record-integrated hypertension management application
10.1161/jaha.123.030884 · 2024
Access to digital health technologies: personalized framework and global perspectives
10.1038/s41569-025-01184-5 · doi-reference
Data interoperability for ambulatory monitoring of cardiovascular disease: a scientific statement from the American Heart Association
10.1161/hcg.0000000000000095 · doi-reference
Cuffless blood pressure measurement devices-international perspectives on accuracy and clinical use: a narrative review
10.1001/jamacardio.2025.0662 · doi-reference
Cuffless devices for the measurement of blood pressure: a scientific statement from the American Heart Association
10.1161/hyp.0000000000000254 · doi-reference
10.1093/eurjpc/zwag058
10.1093/eurjpc/zwag058 · doi-reference
A review of the effect of skin pigmentation on pulse oximeter accuracy
10.1088/1361-6579/acd51a · doi-reference
Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes
10.1097/hjh.0000000000003428 · doi-reference
Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: a real-world prospective observational study
10.1038/s41440-023-01215-z · doi-reference
Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension working group on blood pressure monitoring and cardiovascular variability
10.1097/hjh.0000000000003224 · doi-reference
The geriatrics 5m's: a new way of communicating what we do
10.1111/jgs.14979 · doi-reference
Addition of social determinants of health to coronary heart disease risk prediction: the Multi-Ethnic Study of Atherosclerosis
10.1161/jaha.123.033651 · doi-reference
Risk prediction for atherosclerotic cardiovascular disease with and without race stratification
10.1001/jamacardio.2023.4520 · doi-reference
Atherosclerotic cardiovascular disease risk prediction in disaggregated Asian and Hispanic subgroups using electronic health records
10.1161/jaha.118.011874 · doi-reference
Revising the atherosclerotic cardiovascular disease calculator without race
10.1016/s2589-7500(21)00258-2 · doi-reference
Differences in estimates for 10-year risk of cardiovascular disease in black versus white individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study
10.1016/s2589-7500(21)00236-3 · doi-reference
Addressing structural racism through public policy advocacy: a policy statement from the American Heart Association
10.1161/cir.0000000000001203 · doi-reference
Social determinants of health and premature death among adults in the USA from 1999 to 2018: a national cohort study
10.1016/s2468-2667(23)00081-6 · doi-reference
Social determinants of cardiovascular disease
10.1161/circresaha.121.319811 · doi-reference
Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association
10.1161/cir.0000000000000228 · doi-reference
Team-based care and improved blood pressure control: a community guide systematic review
10.1016/j.amepre.2014.03.004 · doi-reference
Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control
10.1161/circoutcomes.114.001283 · doi-reference
Economics of team-based care for blood pressure control: updated community guide systematic review
10.1016/j.amepre.2023.04.013 · doi-reference
Implementation strategies to improve blood pressure control in the United States: a scientific statement from the American Heart Association and American Medical Association
10.1161/hyp.0000000000000232 · doi-reference
Team-based care for improving hypertension management: a pragmatic randomized controlled trial
10.3389/fcvm.2021.760662 · doi-reference
Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: a systematic review and meta-analysis
10.7326/m17-1805 · doi-reference
Cost-effectiveness and challenges of implementing intensive blood pressure goals and team-based care
10.1007/s11906-019-0996-x · doi-reference
Effectiveness and cost-effectiveness of team-based care for hypertension: a meta-analysis and simulation study
10.1161/hypertensionaha.122.20292 · doi-reference
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation
10.4244/eij-d-19-00902 · doi-reference
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the global SYMPLICITY registry
10.1093/eurheartj/ehz118 · doi-reference
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
10.1016/s0140-6736(22)00455-x · doi-reference
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial
10.4244/eij-d-22-00305 · doi-reference
Long-term clinical benefit after radiofrequency renal denervation: pooled 36-month results from the SPYRAL clinical program
10.4244/eij-d-26-00161 · doi-reference
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
10.1016/s0140-6736(21)00788-1 · doi-reference
Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association
10.1161/hyp.0000000000000240 · doi-reference
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
10.1016/s0140-6736(20)30554-7 · doi-reference
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
10.1016/s0140-6736(18)31082-1 · doi-reference
Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial
10.1001/jama.2023.0713 · doi-reference
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
10.1016/s0140-6736(09)60566-3 · doi-reference
Efficacy of tonlamarsen in patients with uncontrolled hypertension: the KARDINAL phase 2 randomized clinical trial
10.1016/j.jacc.2026.03.034 · doi-reference
Add-on treatment with zilebesiran for inadequately controlled hypertension: the KARDIA-2 randomized clinical trial
10.1001/jama.2025.6681 · doi-reference